European Urology Oncology

Slides:



Advertisements
Similar presentations
Volume 62, Issue 4, Pages (October 2012)
Advertisements

Volume 56, Issue 5, Pages (November 2009)
Volume 55, Issue 1, Pages 1-8 (January 2009)
Volume 54, Issue 2, Pages (August 2008)
Volume 69, Issue 3, Pages (March 2016)
Volume 68, Issue 2, Pages (August 2015)
Testosterone Therapy in Men With Prostate Cancer
Volume 53, Issue 4, Pages (April 2008)
Prostate Cancer 2008: Challenges in Diagnosis and Management
Volume 62, Issue 5, Pages (November 2012)
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 5, Pages (November 2015)
Yair Lotan, Peter C. Black, Laura Caba, Sam S. Chang, Michael S
Volume 63, Issue 4, Pages (April 2013)
European Urology Oncology
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
Elizabeth K. Bancroft, Rosalind A. Eeles
Volume 69, Issue 3, Pages (March 2016)
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Volume 184, Issue 4, Pages (October 2010)
Volume 60, Issue 4, Pages (October 2011)
Volume 66, Issue 3, Pages (September 2014)
Laurent Boccon-Gibod  European Urology Supplements 
Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients  Timo F.W. Soeterik,
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases  Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,
Volume 53, Issue 4, Pages (April 2008)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
European Urology Oncology
Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson
European Urology Oncology
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography  Andrew.
European Urology Oncology
Volume 74, Issue 6, Pages (December 2018)
European Urology Oncology
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
European Urology Oncology
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Volume 59, Issue 4, Pages (April 2011)
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer  Felix Preisser, Michele Marchioni, Sebastiano.
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial  Martin Nyberg, Jonas.
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review  Alexey Surov, Hans Jonas Meyer, Andreas.
The Cost to Medicare of Bladder Cancer Care
Prostate Cancer 2008: Challenges in Diagnosis and Management
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
European Urology Oncology
European Urology Oncology
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 74, Issue 6, Pages (December 2018)
Volume 54, Issue 3, Pages (September 2008)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Does PSA Testing Influence the Natural History of Prostate Cancer?
Salvage Local Treatments After Focal Therapy for Prostate Cancer
European Urology Oncology
European Urology Oncology
Michael Marberger  European Urology Supplements 
European Urology Oncology
Volume 76, Issue 1, Pages (July 2019)
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
European Urology Oncology
Presentation transcript:

European Urology Oncology Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort  Emmeli Palmstedt, Marianne Månsson, Maria Frånlund, Johan Stranne, Carl-Gustaf Pihl, Jonas Hugosson, Rebecka Arnsrud Godtman  European Urology Oncology  DOI: 10.1016/j.euo.2019.01.016 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Profile of the randomised, population-based Göteborg prostate cancer screening trial. European Urology Oncology DOI: (10.1016/j.euo.2019.01.016) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 The 20-yr cumulative prostate cancer mortality (PCM) for men with an initial benign biopsy. PSA=prostate-specific antigen. European Urology Oncology DOI: (10.1016/j.euo.2019.01.016) Copyright © 2019 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.